Condition

Thymic Carcinoma clinical trials and research

• 8Clinical trials
• 3Countries

Newest Thymic Carcinoma clinical trials

All recruiting trials (8)

• Target-Selected CAR-NK Cells for B2 Thymoma or Thymic Carcinoma

  This study tests whether CAR-NK cells targeting CD30, CD5, or mesothelin can be safely given to adults whose B2 thymoma or thymic carcinoma has come back or not responded to treatment.

  Recruiting Phase 1/2 Beijing Biotech · Shenzhen, Guangdong · NCT07598955

• Sacituzumab Tirumotecan for locally advanced or metastatic thymic carcinoma

  This trial tests whether Sac-TMT can help people with thymic carcinoma after one prior platinum-based therapy.

  Recruiting Phase 2 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Shanghai · NCT07324629

• Tislelizumab plus anlotinib as a second-line treatment for thymoma and thymic carcinoma

  This trial will test whether combining tislelizumab with anlotinib is safe and can control thymoma or thymic carcinoma in people whose cancer progressed after first-line chemotherapy (with or without immunotherapy).

  Recruiting Phase 2 The First Affiliated Hospital with Nanjing Medical University · Nanjing, Jiangsu · NCT06838910

• Adjuvant chemotherapy for thymic cancer after surgery

  This study is testing if adding chemotherapy to radiation treatment after surgery helps people with thymic cancer stay healthier and avoid the cancer coming back.

  Recruiting Phase 3 Fudan University · Shanghai, Shanghai Municipality · NCT06402708

• Using AI to improve diagnosis and recurrence prediction in thymic tumors

  This study is testing if artificial intelligence can help doctors better diagnose thymic tumors and predict the chances of them coming back for patients with these rare cancers.

  Recruiting Erasmus Medical Center · Rotterdam, South Holland · NCT06301945

• Testing a new treatment for advanced thymic tumors

  This study is testing a new drug to see if it can help adults with advanced thymic tumors who haven't had success with other treatments.

  Recruiting at 4 sites Phase 2 Georgetown University · Palo Alto, California and 3 other locations · NCT06248515

• Neoadjuvant treatment for advanced thymic cancer

  This study is testing a new treatment that combines a medication with radiation therapy to see if it can help people with advanced thymic cancer have better surgery outcomes.

  Recruiting Phase 2 Shanghai Pulmonary Hospital, Shanghai, China · Shanghai, Shanghai Municipality · NCT06019468

• Analysis and treatment options for thymic cancers

  This study is trying to find out how genetic changes in thymic cancers can help doctors create better, personalized treatments for patients.

  Recruiting Shanghai Chest Hospital · Shanghai, Shanghai Municipality · NCT05667948

Related topics

Quick answers

How many Thymic Carcinoma clinical trials are recruiting right now?

8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in China (6 trials), United States (1 trial), Netherlands (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 4, Phase 3: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →